Mein Warenkorb

4-1BB & CD64

Produktanfrage

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
TR-009NOV-1501; ABL001-ABL Bio; CTX-009; HD-B001A; ABL-001-ABL Bio; HDB001A; TR-009; ES-104Phase 3 ClinicalAbl Bio IncBiliary Tract Neoplasms; Solid tumours; Rectal Neoplasms; Colonic Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Bile Duct Neoplasms; Ampullary Carcinoma; Gallbladder Neoplasms
Details
NavicixizumabOMP-305B83Phase 3 ClinicalOncomed Pharmaceuticals IncOvarian Neoplasms; Solid tumours; Stomach Neoplasms; Triple Negative Breast Neoplasms; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms
Details
DilpacimabABT-165; DVD-Ig ABT-165Phase 1 ClinicalAbbvie IncSolid tumours; Neoplasms
Details
  • Produktanfrage
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns